Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
2.310
-0.160 (-6.48%)
Jun 16, 2026, 4:00 PM EDT - Market closed
Jaguar Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.28 | 0.97 | 8 | 6.47 | 5.47 | 17.05 |
Cash & Short-Term Investments | 7.28 | 0.97 | 8 | 6.47 | 5.47 | 17.05 |
Cash Growth | 27.91% | -87.90% | 23.70% | 18.29% | -67.93% | 110.77% |
Accounts Receivable | 0.07 | 1.52 | 1.53 | 1.97 | 1.88 | 1.71 |
Other Receivables | 0.21 | 0.18 | 0.12 | 0.22 | 0.59 | 0.44 |
Total Trade Receivables | 0.28 | 1.7 | 1.65 | 2.18 | 2.47 | 2.14 |
Inventory | 7.82 | 8.6 | 10.35 | 9.19 | 7.02 | 4.9 |
Other Current Assets | 4.83 | 9.08 | 12.2 | 10.12 | 7.36 | 4.34 |
Total Current Assets | 20.21 | 20.35 | 32.2 | 27.96 | 22.32 | 28.43 |
Net Property, Plant & Equipment | 1.5 | 1.46 | 1.4 | 1.67 | 1.7 | 1.73 |
Other Intangible Assets | 15.55 | 16.02 | 18.48 | 20.12 | 22.44 | 22.65 |
Other Long-Term Assets | 0.17 | 0.49 | 1.35 | 1.01 | 1 | 0.45 |
Total Assets | 37.43 | 38.32 | 53.43 | 50.76 | 47.45 | 53.27 |
Accounts Payable | 4.96 | 8.69 | 5.29 | 4.97 | 5.81 | 4.93 |
Accrued Expenses | 3.75 | 4.17 | 1.91 | 3.8 | 8.17 | 7.12 |
Short-Term Debt | 22.08 | 27.44 | 12.04 | 4.87 | 15.88 | 3.18 |
Current Portion of Leases | 0.26 | 0.19 | 0.3 | 0.35 | 0.48 | 0.24 |
Unearned Revenue | 0.17 | 0.17 | 0.17 | 0.3 | - | - |
Other Current Liabilities | 9.47 | - | - | - | - | 0 |
Total Current Liabilities | 40.69 | 40.65 | 19.7 | 13.99 | 30.34 | 15.47 |
Long-Term Debt | 11.08 | 15.08 | 23.5 | 30.99 | 17.74 | 25.02 |
Long-Term Leases | 0.9 | 0.89 | 0.69 | 0.89 | 0.73 | 0.92 |
Other Long-Term Liabilities | 0.53 | 0.38 | 0.55 | - | - | - |
Total Long-Term Liabilities | 12.5 | 16.36 | 24.74 | 31.88 | 18.47 | 25.94 |
Total Liabilities | 53.19 | 57.01 | 44.45 | 45.87 | 48.81 | 41.41 |
Preferred Stock | - | 2.49 | - | - | - | - |
Common Stock | 0 | 0 | - | - | - | - |
Additional Paid-in Capital | 378.13 | 380.97 | 354.23 | 313.86 | 266.97 | 231.11 |
Accumulated Other Comprehensive Income | -1.24 | -0.83 | -0.47 | -0.65 | -0.68 | - |
Retained Earnings | -391.07 | -399.92 | -346.48 | -308.25 | -266.95 | -219.49 |
Total Common Shareholders' Equity | -14.18 | -17.29 | 7.29 | 4.96 | -0.66 | 11.61 |
Minority Interest | -1.57 | -1.4 | 1.69 | -0.06 | -0.7 | 0.24 |
Shareholders' Equity | -15.75 | -18.69 | 8.98 | 4.9 | -1.36 | 11.85 |
Total Liabilities & Equity | 37.43 | 38.32 | 53.43 | 50.76 | 47.45 | 53.27 |
Total Debt | 34.31 | 43.61 | 36.53 | 37.09 | 34.84 | 29.37 |
Net Cash (Debt) | -27.03 | -42.64 | -28.52 | -30.63 | -29.37 | -12.31 |
Net Cash Per Share | -146.24 | -639.84 | -3389.56 | -69507.49 | -1175519.29 | -1084379.79 |
Book Value | -14.18 | -17.29 | 7.29 | 4.96 | -0.66 | 11.61 |
Book Value Per Share | -76.70 | -259.44 | 865.69 | 11259.60 | -26299.70 | 1022470.00 |
Tangible Book Value | -29.73 | -33.31 | -11.19 | -15.16 | -23.1 | -11.04 |
Tangible Book Value Per Share | -160.83 | -499.85 | -1330.20 | -34396.30 | -924531.00 | -972190.00 |